BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Antares Pharma Reports Third Quarter 2017 Operating and Financial Results

  The Company reported record revenue of $15.1 million and a net loss per share of $0.03 for the three months ended September 30, 2017.

  November 7, 2017

   · 

  12 min read
• BioMidwest

  sciNote to Incorporate Artificial Intelligence Into its Electronic Lab Notebook

  The sciNote Manuscript Writer add-on will allow researchers to generate a draft of a scientific manuscript using data stored by the user on its platform and relevant references.

  November 7, 2017

   · 

  1 min read
• Policy

  OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros 1 Platform

  The filing contains clinical data from the Company’s 864-patient Total PSA clinical study.

  November 7, 2017

   · 

  5 min read
• Drug Development

  Trevena Reports Third Quarter 2017 Financial Results and Announces New Positive Clinical Trial Data

  The company announced positive new data from both its OLINVOTM (oliceridine injection) and TRV250 programs.

  November 7, 2017

   · 

  11 min read
• Pharm Country

  BioIVT to Present Advances in Immunohistochemistry at AAPS Annual Meeting

  This conference will be held from Nov. 12-15 at the San Diego Convention Center in San Diego, CA.

  November 7, 2017

   · 

  2 min read
• Business

  Argos Announces Receipt of Milestone Payment From Lummy (Hong Kong) Co. Ltd.

  The milestone payment was made in consideration of the successful initiation of technology transfer related to the manufacturing of Rocapuldencel-T to Lummy by the Company, to which Lummy has a license for commercialization in these territories.

  November 7, 2017

   · 

  3 min read
• 

  FDA

  Roche Wins FDA Nod for VENTANA ALK (D5F3) CDx Assay

  The VENTANA ALK (D5F3) CDx Assay is the only test FDA-approved as a companion diagnostic for ALECENSA.

  November 7, 2017

   · 

  5 min read
• Business

  Supernus Announces Third Quarter 2017 Financial Results

  Increased full year 2017 net product sales guidance range to $290 million to $295 million, from $280 million to $290 million.

  November 7, 2017

   · 

  12 min read
• Drug Development

  AnaptysBio Reports Positive ANB019 Top-line Phase I Clinical Trial Results

  Top-line data demonstrated favorable safety, pharmacokinetics and pharmacodynamic properties that support advancement of ANB019 into patient Phase 2 studies.

  November 7, 2017

   · 

  6 min read
• Business

  Voyager Therapeutics Announces Proposed Offering of Common Stock

  In addition, Voyager intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering.

  November 7, 2017

   · 

  4 min read